Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Warren

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Biochemistry|November 4, 1986
Nuclear magnetic resonance study of the state of protonation of inhibitors bound to mutant dihydrofolate reductase lacking the active-site carboxylR E London, E E Howell, M S Warren, et al.
Biochemistry|December 29, 1987
Construction of an altered proton donation mechanism in Escherichia coli dihydrofolate reductaseE E Howell, M S Warren, C L Booth, et al.
Biochemistry|November 19, 1991
Investigation of the functional role of tryptophan-22 in Escherichia coli dihydrofolate reductase by site-directed mutagenesisM S Warren, K A Brown, M F Farnum, et al.
Oncogene|July 11, 2012
Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivoH Gil-Henn, A Patsialou, Y Wang, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Functionalized analogues of 5,8,10-trideazafolate: development of an enzyme-assembled tight binding inhibitor of GAR Tfase and a potential irreversible inhibitor of AICAR TfaseD L Boger, N E Haynes, M S Warren, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Multisubstrate analogue based on 5,8,10-trideazafolateD L Boger, N E Haynes, M S Warren, et al.
Journal of Bacteriology|May 16, 2000
Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistanceA Lee, W Mao, M S Warren, et al.
Circulation|February 27, 2001
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failureB Bozkurt, G Torre-Amione, M S Warren, et al.
Biochemistry|December 10, 1991
Analysis of hydride transfer and cofactor fluorescence decay in mutants of dihydrofolate reductase: possible evidence for participation of enzyme molecular motions in catalysisM F Farnum, D Magde, E E Howell, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Abenzyl 10-formyl-trideazafolic acid (abenzyl 10-formyl-TDAF): an effective inhibitor of glycinamide ribonucleotide transformylaseD L Boger, N E Haynes, M S Warren, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biochemistry|November 4, 1986
Nuclear magnetic resonance study of the state of protonation of inhibitors bound to mutant dihydrofolate reductase lacking the active-site carboxylR E London, E E Howell, M S Warren, et al.
Biochemistry|December 29, 1987
Construction of an altered proton donation mechanism in Escherichia coli dihydrofolate reductaseE E Howell, M S Warren, C L Booth, et al.
Biochemistry|November 19, 1991
Investigation of the functional role of tryptophan-22 in Escherichia coli dihydrofolate reductase by site-directed mutagenesisM S Warren, K A Brown, M F Farnum, et al.
Oncogene|July 11, 2012
Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivoH Gil-Henn, A Patsialou, Y Wang, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Functionalized analogues of 5,8,10-trideazafolate: development of an enzyme-assembled tight binding inhibitor of GAR Tfase and a potential irreversible inhibitor of AICAR TfaseD L Boger, N E Haynes, M S Warren, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Multisubstrate analogue based on 5,8,10-trideazafolateD L Boger, N E Haynes, M S Warren, et al.
Journal of Bacteriology|May 16, 2000
Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistanceA Lee, W Mao, M S Warren, et al.
Circulation|February 27, 2001
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failureB Bozkurt, G Torre-Amione, M S Warren, et al.
Biochemistry|December 10, 1991
Analysis of hydride transfer and cofactor fluorescence decay in mutants of dihydrofolate reductase: possible evidence for participation of enzyme molecular motions in catalysisM F Farnum, D Magde, E E Howell, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Abenzyl 10-formyl-trideazafolic acid (abenzyl 10-formyl-TDAF): an effective inhibitor of glycinamide ribonucleotide transformylaseD L Boger, N E Haynes, M S Warren, et al.
Pageof 3